<DOC>
	<DOCNO>NCT02603952</DOCNO>
	<brief_summary>The purpose study evaluate safety tolerability single dose MEDI8852 give oseltamivir , safety tolerability oseltamivir alone , safety tolerability single dose MEDI8852 alone adult subject acute , uncomplicated influenza cause Type A strain .</brief_summary>
	<brief_title>A Phase 2a Evaluate Safety MEDI8852 Adults With Uncomplicated Influenza</brief_title>
	<detailed_description>The MEDI8852 phase 2a study evaluate safety tolerability single intravenous ( IV ) dose MEDI8852 administer conjunction oseltamivir , safety tolerability oseltamivir alone safety tolerability single IV dose MEDI8852 alone adult subject confirm acute , uncomplicated influenza cause Type A strain . Enrollment plan approximately 50 site United States , South Africa , Australia .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<mesh_term>Oseltamivir</mesh_term>
	<criteria>Age 18 65 year time screen . Symptomatic presumptive Influenza A infection onset symptom ≤ 5 day prior MEDI8852 administration define presence : Fever ≥ 38.0ºC ( 100.4°F ) screening AND ≥ 1 moderate systemic symptom ( headache , malaise , myalgia , sweat and/or chill , fatigue ) AND 1 moderate respiratory symptom ( cough , sore throat , nasal symptom ) Influenza A infection confirm positive rapid antigen test Able complete followup period Day 101 require protocol ( include telephone followup Days 11 101 ) Females childbearing potential sexually active nonsterilized male partner must use highly effective method contraception least 2 day prior first dose investigational product must agree continue use precaution Day 101 study Hospitalized subject . Receipt influenza antiviral therapy within precede 14 day . Receipt immunoglobulin blood product within 6 month prior screen . Known immunodeficiency due illness , include HIV , due drug , include course glucocorticoid therapy exceed 2 week prednisone equivalent dose 20 mg daily every day within 6 month prior screen . Current clinical evidence pneumonia . Active bacterial infection require treatment oral parenteral antibiotic . History malignancy treat nonmelanoma skin cancer locallytreated cervical cancer previous 3 year . Any planned surgical procedure completion Day 101 .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Influenza</keyword>
	<keyword>Influenza A</keyword>
	<keyword>Flu</keyword>
	<keyword>Flu A</keyword>
</DOC>